Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

NCT00118196 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Due to limited resources available to conduct study

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: arsenic trioxide
DRUG: azacitidine

Sponsor

Medical University of South Carolina